Company: SCLXW
Filing Date: 2025-05-15
Form Type: 424B3
Source: 0000950170-25-071914
Chunk: 87

Company: Scilex Holding Co
Filing Date: 2025-05-15
Form: 424B3
Chunk 87
---
 our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information. Our existing cash and cash equivalents may be insufficient to enable us to fund our operating expenses, capital expenditure requirements, and to service our debt obligations (whether under the Oramed Note, the Tranche B Notes or otherwise) for at least the next 12 months. If these sources are insufficient to satisfy our liquidity requirements, we may seek to raise additional funds through equity offerings, debt financings, collaborations, government contracts or other strategic transactions.

<div align='center'>49</div>

Cash Flows The following table summarizes our cash flows for each of the periods presented (in thousands):

| Cash Flow Data:                                          |     | Three Months Ended March 31, 
 2025                         |        |   |     | 2024 |         |   |
|:---------------------------------------------------------|:----|:-----------------------------|-------:|:--|:----|:-----|--------:|:--|
| Net cash proceeds from operating activities              |     | $                            |  6,007 |   |     | $    |   9,391 |   |
| Net cash used for investing activities                   |     |                              |   (395 | ) |     |      |    (150 | ) |
| Net cash used for financing activities                   |     |                              | (3,084 | ) |     |      | (11,196 | ) |
| Net change in cash, cash equivalents and restricted cash |     | $                            |  2,528 |   |     | $    |  (1,955 | ) |

Cash Flows from Operating Activities For the three months ended March 31, 2025, net cash proceeds from operating activities were approximately $6.0 million, attributable to the changes in operating assets and liabilities that provided $27.2 million of cash and other non-cash reconciling items of $4.9 million related to stock-based compensation, change in fair value of debt and liability instruments, financing costs, depreciation and amortization and non-cash operating lease cost and change on fair value of derivative liabilities, partially offset by our net loss of $26.1 million. For the three months ended March 31, 2024, net cash proceeds from operating activities were approximately $9.3 million, attributable to the changes in operating assets and liabilities that provided $23.1 million of cash and other non-cash reconciling items of $